Professor KIM THOMAS KIM.THOMAS@NOTTINGHAM.AC.UK
Professor of Applied Dermatology Research
Randomised controlled trial of topical corticosteroid and home‐based narrowband UVB for active and limited vitiligo: results of the HI‐Light Vitiligo trial
Thomas, K.S.; Batchelor, J. M.; Akram, P.; Chalmers, J. R.; Haines, RH; Meakin, G. D.; Duley, L.; Ravenscroft, J. C.; Rogers, A.; Sach, T. H.; Santer, M.; Tan, W.; White, J.; Whitton, M. E.; Williams, H. C.; Cheung, S. T.; Hamad, H.; Wright, A.; Ingram, J. R.; Levell, N. J.; Goulding, J. M. R.; Makrygeorgou, A.; Bewley, A.; Ogboli, M.; Stainforth, J.; Ferguson, A.; Laguda, B.; Wahie, S.; Ellis, R.; Azad, J.; Rajasekaran, A.; Eleftheriadou, V.; Montgomery, A. A.
Authors
J. M. Batchelor
P. Akram
J. R. Chalmers
RH Haines
GARRY MEAKIN Garry.Meakin@nottingham.ac.uk
Senior Trial Manager
L. Duley
J. C. Ravenscroft
A. Rogers
T. H. Sach
M. Santer
W. Tan
JENNIFER WHITE Jennifer.White@nottingham.ac.uk
Clinical Trial Manager
M. E. Whitton
HYWEL WILLIAMS HYWEL.WILLIAMS@NOTTINGHAM.AC.UK
Professor of Dermato-Epidemiology
S. T. Cheung
H. Hamad
A. Wright
J. R. Ingram
N. J. Levell
J. M. R. Goulding
A. Makrygeorgou
A. Bewley
M. Ogboli
J. Stainforth
A. Ferguson
B. Laguda
S. Wahie
R. Ellis
J. Azad
A. Rajasekaran
V. Eleftheriadou
ALAN MONTGOMERY ALAN.MONTGOMERY@NOTTINGHAM.AC.UK
Director Nottingham Clinical Trials Unit
Abstract
Background
Evidence for the effectiveness of vitiligo treatments is limited.
Objectives
To determine effectiveness of (a) hand‐held narrowband‐UVB (NB‐UVB) and (b) combination of potent topical corticosteroid (TCS) and NB‐UVB compared to TCS, for localised vitiligo.
Methods
Pragmatic, 3‐arm, placebo‐controlled RCT (9 months’ treatment; 12 months’ follow‐up). Adults and children, recruited from secondary care and community, aged ≥5 years with active vitiligo affecting 75% expected were more likely to achieve treatment success, but effects were lost once treatment stopped. Localised grade 3 or 4 erythema was reported in 62 (12%) participants (including 3 with dummy light). Skin thinning was reported in 13 (2.5%) participants (including 1 with placebo ointment).
Conclusion
Combination treatment with home‐based hand‐held NB‐UVB plus TCS is likely to be superior to TCS alone for treatment of localised vitiligo. Combination treatment was relatively safe and well tolerated but was only successful in around a quarter of participants.
Citation
Thomas, K., Batchelor, J. M., Akram, P., Chalmers, J. R., Haines, R., Meakin, G. D., …Montgomery, A. A. (2021). Randomised controlled trial of topical corticosteroid and home‐based narrowband UVB for active and limited vitiligo: results of the HI‐Light Vitiligo trial. British Journal of Dermatology, 184(5), 828-839. https://doi.org/10.1111/bjd.19592
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 29, 2020 |
Online Publication Date | Oct 2, 2020 |
Publication Date | 2021-05 |
Deposit Date | Oct 12, 2020 |
Publicly Available Date | Oct 3, 2021 |
Journal | British Journal of Dermatology |
Print ISSN | 0007-0963 |
Electronic ISSN | 1365-2133 |
Publisher | Oxford University Press (OUP) |
Peer Reviewed | Peer Reviewed |
Volume | 184 |
Issue | 5 |
Pages | 828-839 |
DOI | https://doi.org/10.1111/bjd.19592 |
Keywords | Dermatology |
Public URL | https://nottingham-repository.worktribe.com/output/4959896 |
Publisher URL | https://onlinelibrary.wiley.com/doi/10.1111/bjd.19592 |
Files
Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial
(802 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search